Augmentation of the effects of vasoactive intestinal peptide aerosol on pulmonary hypertension via coapplication of a neutral endopeptidase 24.11 inhibitor

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vasodilatory Effect of the Stable Vasoactive Intestinal Peptide Analog RO 25-1553 in Murine and Rat Lungs

(2013) Jun Yin et al.   PLoS One

Inhalable sustained-release formulation of long-acting vasoactive intestinal peptide derivative alleviates acute airway inflammation

(2012) Satomi Onoue et al.   PEPTIDES

Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis

(2010) Antje Prasse et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?

(2010) S. I. Said et al.   EUROPEAN RESPIRATORY JOURNAL

Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs

(2010) Amali E. Samarasinghe et al.   REGULATORY PEPTIDES

Preserved pulmonary vasodilative properties of aerosolized brain natriuretic peptide

(2009) Hanno H. Leuchte et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Inhalation of endothelin receptor blockers in pulmonary hypertension

(2008) Hanno H. Leuchte et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Liposomal vasoactive intestinal peptide for lung application: Protection from proteolytic degradation

(2008) B STARK et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Inhalation of vasoactive intestinal peptide in pulmonary hypertension

(2008) H. H. Leuchte et al.   EUROPEAN RESPIRATORY JOURNAL